- Home
- IVZ vs TECH Comparison
IVZ vs TECH Comparison
Compare IVZ & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVZ
- TECH
- Stock Information
- Founded
- IVZ 1935
- TECH 1976
- Country
- IVZ United States
- TECH United States
- Employees
- IVZ N/A
- TECH N/A
- Industry
- IVZ Investment Managers
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IVZ Finance
- TECH Health Care
- Exchange
- IVZ Nasdaq
- TECH Nasdaq
- Market Cap
- IVZ 10.5B
- TECH 8.9B
- IPO Year
- IVZ 1995
- TECH 1989
- Fundamental
- Price
- IVZ $24.31
- TECH $65.87
- Analyst Decision
- IVZ Hold
- TECH Strong Buy
- Analyst Count
- IVZ 16
- TECH 14
- Target Price
- IVZ $22.66
- TECH $71.23
- AVG Volume (30 Days)
- IVZ 4.4M
- TECH 2.1M
- Earning Date
- IVZ 10-28-2025
- TECH 11-05-2025
- Dividend Yield
- IVZ 3.47%
- TECH 0.49%
- EPS Growth
- IVZ N/A
- TECH N/A
- EPS
- IVZ 1.47
- TECH 0.49
- Revenue
- IVZ $6,278,100,000.00
- TECH $1,216,732,000.00
- Revenue This Year
- IVZ N/A
- TECH $3.64
- Revenue Next Year
- IVZ $11.23
- TECH $7.59
- P/E Ratio
- IVZ $16.47
- TECH $135.29
- Revenue Growth
- IVZ 6.64
- TECH 3.85
- 52 Week Low
- IVZ $11.60
- TECH $46.01
- 52 Week High
- IVZ $24.75
- TECH $79.28
- Technical
- Relative Strength Index (RSI)
- IVZ 59.51
- TECH 66.11
- Support Level
- IVZ $22.32
- TECH $57.02
- Resistance Level
- IVZ $23.75
- TECH $62.31
- Average True Range (ATR)
- IVZ 0.79
- TECH 2.21
- MACD
- IVZ 0.02
- TECH 0.47
- Stochastic Oscillator
- IVZ 84.70
- TECH 99.42
About IVZ Invesco Ltd
Invesco provides investment-management services to retail (70% of managed assets) and institutional (30%) clients. At the end of September 2025, the firm had $2.125 trillion in assets under management spread among its equity (60% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (10%) operations. Passive products account for 47% of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 31% of its AUM sourced from Europe, Africa, and the Middle East (16%) and Asia (15%).
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.